ICR Clinical Trials and Statistics Unit
The Cancer Research UK funded ICR Clinical Trials and Statistics Unit (ICR-CTSU) is a research lead, academic trials unit embedded within the Division of Clinical Studies at The Institute of Cancer Research, and has been established since the 1980s.
The main objective of the ICR-CTSU is to lead the design, conduct and analysis of multi-centre national and international randomised controlled clinical trials of cancer treatments which will directly influence routine clinical practice within the NHS and worldwide.
The ICR-CTSU is one of only nine cancer clinical trials units to be accredited by the National Cancer Research Institute (NCRI) and is UK Clinical Research Collaboration (UK CRC) registered.
ICR-CTSU trials form an important component of the national portfolio of randomised trials in breast cancer, urological cancers, head and neck cancers, radiotherapy techniques and we have an expanding portfolio of exploratory phase II targeted treatment trials and trials in rarer tumour groups.